Table 3.
Clinical case characteristics | Number of Studies | Heterogeneity test results | Effect model | Meta-analysis results | ||
---|---|---|---|---|---|---|
I2 (%) | P | OR (95% CI) | P | |||
Number of metastases | 8 | 10 | 0.35 | Fixed-effects model | 1 (0.76–1.31) | P = 0.97 |
CEA | 6 | 46 | 0.1 | Fixed-effects model | 1.31 (0.88–1.96) | P = 0.19 |
Primary tumor size | 6 | 0 | 0.89 | Fixed-effects model | 1.22 (0.90–1.67) | P = 0.2 |
Time to metastasis | 4 | 0 | 0.89 | Fixed-effects model | 1.12 (0.78–1.62) | P = 0.54 |
Number of metastases, > 3 or < 3; CEA, > CEA cut-off or < CEA cut-off; primary tumor size, > 5 cm or < 5 cm; time to metastasis, Synchronous transfer or Metachronous transfer